Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  ACB | T.ACB.WS.U

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by MeAndMyTwoCentson Dec 30, 2016 1:32pm
105 Views
Post# 25654311

RE:RE:RE:RE:RE:Sheep herding to greener pastures or the slaughterhouse?

RE:RE:RE:RE:RE:Sheep herding to greener pastures or the slaughterhouse?Seeing as you decided to pick on the P/E ratio as the most appropriate valuation metric, can you tell me what happens to that ratio when the "E" goes up faster than the "P"? If someone bought Apple years ago at 80 x earnings (which is where it was trading) and sold it at 8 x earnings years later after the share price had quadrupled, does that mean it was a bad investment? And since when is it forbidden for a company in a brand new industry to be trading at a multiple many times higher than other companies that are already established. Why is Netflix or any oil company such a good comparison? It seems to me Steve, that you are simply slapping together emails to support your opinion (or agenda), however, I would urge you to do a better job of supporting your argument than simply saying that just because some oil company has a P/E of 20 x earnings that means that ACB is overvalued. By the way, are you using trailing P/E or forward P/E, because that is kind of crucial in this case.
Bullboard Posts